Zimmer Biomet (ZBH) PT Raised to $150 at Canaccord Genuity, Ahead Of Earnings
Tweet Send to a Friend
Canaccord Genuity analyst Kyle Rose raised the price target on Zimmer Biomet (NYSE: ZBH) to $150.00 (from $137.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
